Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats

Chrysin (5, 7- dihydroxyflavone) is a flavonoid with several pharmacological properties that include antioxidant, anti-inflammatory and antiapoptotic activities. in this work, we investigated some effects of three graded oral doses of chrysin (10, 50 and 250 mg/kg) on kidney structure and function i...

Full description

Bibliographic Details
Main Authors: Ali, Badreldin H., Adham, Sirin A., Al Za’abi, Mohammed, Waly, Mostafa I., Yasin, Javed, Nemmar, Abderrahim, Schupp, Nicole
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409384/
id pubmed-4409384
recordtype oai_dc
spelling pubmed-44093842015-05-12 Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats Ali, Badreldin H. Adham, Sirin A. Al Za’abi, Mohammed Waly, Mostafa I. Yasin, Javed Nemmar, Abderrahim Schupp, Nicole Research Article Chrysin (5, 7- dihydroxyflavone) is a flavonoid with several pharmacological properties that include antioxidant, anti-inflammatory and antiapoptotic activities. in this work, we investigated some effects of three graded oral doses of chrysin (10, 50 and 250 mg/kg) on kidney structure and function in rats with experimental chronic renal disease (CKD) induced by adenine (0.25% w/w in feed for 35 days), which is known to involve inflammation and oxidative stress. Using several indices in plasma, urine and kidney homogenates, adenine was found to impair kidney function as it lowered creatinine clearance and increased plasma concentrations of creatinine, urea, neutrophil gelatinase-associated lipocalin and N-Acetyl-beta-D-glucosaminidase activity. Furthermore, it raised plasma concentrations of the uremic toxin indoxyl sulfate, some inflammatory cytokines and urinary albumin concentration. Renal morphology was severely damaged and histopathological markers of inflammation and fibrosis were especially increased. In renal homogenates, antioxidant indices, including superoxide dismutase and catalase activities, total antioxidant capacity and reduced glutathione were all adversely affected. Most of these adenine – induced actions were moderately and dose -dependently mitigated by chrysin, especially at the highest dose. Chrysin did not cause any overt adverse effect on the treated rats. The results suggest that different doses of chrysin produce variable salutary effects against adenine-induced CKD in rats, and that, pending further pharmacological and toxicological studies, its usability as a possible ameliorative agent in human CKD should be considered. Public Library of Science 2015-04-24 /pmc/articles/PMC4409384/ /pubmed/25909514 http://dx.doi.org/10.1371/journal.pone.0125285 Text en © 2015 Ali et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Ali, Badreldin H.
Adham, Sirin A.
Al Za’abi, Mohammed
Waly, Mostafa I.
Yasin, Javed
Nemmar, Abderrahim
Schupp, Nicole
spellingShingle Ali, Badreldin H.
Adham, Sirin A.
Al Za’abi, Mohammed
Waly, Mostafa I.
Yasin, Javed
Nemmar, Abderrahim
Schupp, Nicole
Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats
author_facet Ali, Badreldin H.
Adham, Sirin A.
Al Za’abi, Mohammed
Waly, Mostafa I.
Yasin, Javed
Nemmar, Abderrahim
Schupp, Nicole
author_sort Ali, Badreldin H.
title Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats
title_short Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats
title_full Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats
title_fullStr Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats
title_full_unstemmed Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats
title_sort ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats
description Chrysin (5, 7- dihydroxyflavone) is a flavonoid with several pharmacological properties that include antioxidant, anti-inflammatory and antiapoptotic activities. in this work, we investigated some effects of three graded oral doses of chrysin (10, 50 and 250 mg/kg) on kidney structure and function in rats with experimental chronic renal disease (CKD) induced by adenine (0.25% w/w in feed for 35 days), which is known to involve inflammation and oxidative stress. Using several indices in plasma, urine and kidney homogenates, adenine was found to impair kidney function as it lowered creatinine clearance and increased plasma concentrations of creatinine, urea, neutrophil gelatinase-associated lipocalin and N-Acetyl-beta-D-glucosaminidase activity. Furthermore, it raised plasma concentrations of the uremic toxin indoxyl sulfate, some inflammatory cytokines and urinary albumin concentration. Renal morphology was severely damaged and histopathological markers of inflammation and fibrosis were especially increased. In renal homogenates, antioxidant indices, including superoxide dismutase and catalase activities, total antioxidant capacity and reduced glutathione were all adversely affected. Most of these adenine – induced actions were moderately and dose -dependently mitigated by chrysin, especially at the highest dose. Chrysin did not cause any overt adverse effect on the treated rats. The results suggest that different doses of chrysin produce variable salutary effects against adenine-induced CKD in rats, and that, pending further pharmacological and toxicological studies, its usability as a possible ameliorative agent in human CKD should be considered.
publisher Public Library of Science
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409384/
_version_ 1613215556728520704